Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
By A. M. Shapiro, J. Lakey, E. Ryan, G. Korbutt, E. Toth, G. Warnock, N. Kneteman, R. Rajotte. New England Journal of Medicine, 2000
3,081 citations recorded by the source corpus.
Subfields: Genetics, Surgery, Transplantation
View Paper: https://www.semanticscholar.org/paper/d944cdcaac7b341ebdf2142f871c7e6a151ee5a3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy (2005, methodology): “At the same time, the health of human islet preparations was examined in the cell perifusion system (Wang et al. 1997) and perifusate fractions were assayed for insulin by radioimmunoassay (Brissova et al. 2002).”
- Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor (2002, background): “This activity, which effectively blocks IL-2 stimulation of lymphocyte division, is the basis for the recent successful clinical use of RAPA to prevent allograft rejection in organ transplantatio”
- Tolerance, not immunity, crucially depends on IL-2 (2004, background): “In clinical settings, IL-2R blockade has shown some efficacy at blocking transplant rejection responses and autoimmune diseas”